Novan Inc
Biotechnology
Healthcare
NOVN
24.46 M shares
NASDAQ US
traded
21 Apr 2023
listed
yes
open
1.34
52 week high
4.98
high
1.36
52 week low
1.32
low
1.28
growth
-53.90 %
previous Close
1.33
P/E ratio
market cap
33.02 M
div yield
0
usd
Sep 2022
qoq
revenue
5.12 M
-16.94 %
net incoming
-6.03 M
0.00 %
eps
0.00 %
45.65 %
eps surprise
35.90 %
net profit margin
-117.89 %
-117.00 %
operating incoming
-9.80 M
10.04 %
net change in cash
-22.40 M
-1.00 %
cash on hand
14.90 M
-60.05 %
cost of revenue
1.44 M
-44.87 %
top top